1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 31-40 of 55 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2011Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetesDeane, A.; Summers, M.; Zaknic, A.; Chapman, M.; Fraser, R.; Di Bartolomeo, A.; Wishart, J.; Horowitz, M.
2011Student approaches for learning in medicine: What does it tell us about the informal curriculum?Zhang, J.; Peterson, R.; Ozolins, I.
2011Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohortNikpour, M.; Hissaria, P.; Byron, J.; Sahhar, J.; Micallef, M.; Paspaliaris, W.; Roddy, J.; Nash, P.; Sturgess, A.; Proudman, S.; Stevens, W.
2011Endogenous testosterone and mortality in men: A systematic review and meta-analysisAraujo, A.; Dixon, J.; Suarez, E.; Murad, M.; Guey, L.; Wittert, G.
2011Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapseLevis, M.; Lewis, I.
2011Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancerHaller, D.; Tabernero, J.; Maroun, J.; de Braud, F.; Price, T.; Van Cutsem, E.; Hill, M.; Gilberg, F.; Rittweger, K.; Schmoll, H.
2011Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up resultsKantarjian, H.; Giles, F.; Bhalla, K.; Pinilla-Ibarz, J.; Larson, R.; Gattermann, N.; Ottmann, O.; Hochhaus, A.; Radich, J.; Saglio, G.; Hughes, T.; Martinelli, G.; Kim, D.; Shou, Y.; Gallagher, N.; Blakesley, R.; Baccarani, M.; Cortes, J.; le Coutre, P.
2011Clinical manifestations of highly prevalent corticosteroid-binding globulin mutations in a village in Southern ItalyCizza, G.; Bernardi, L.; Smirne, N.; Maletta, R.; Tomaino, C.; Costanzo, A.; Gallo, M.; Lewis, J.; Geracitano, S.; Grasso, M.; Potenza, G.; Monteleone, C.; Brancati, G.; Ho, J.; Torpy, D.; Bruni, A.
2011Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b studyKotasek, D.; Tebbutt, N.; Desai, J.; Welch, S.; Siu, L.; McCoy, S.; Sun, Y.; Johnson, J.; Adewoye, A.; Price, T.
2011Complex problems require complex solutions: the utility of social quality theory for addressing the social determinants of healthWard, P.; Meyer, S.; Verity, F.; Gill, T.; Luong, T.

Discover